A Causal Relationship Between Genetically Proxied Inhibition of HMGCR, NPC1L1, and PCSK9 and Cancers

QR Code

A Causal Relationship Between Genetically Proxied Inhibition of HMGCR, NPC1L1, and PCSK9 and Cancers

Saved in:

Bibliographic Details
Main Authors:	Xin Wang, Yiyao Zeng, Zihan Xu, Xiangyue Meng, Jie Chen
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.70026
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CO18 | Relationship between gut permeability and PCSK9 in heterozygous familial hypercholesterolemia
Published: (2025-07-01)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)

Analysis of The Use of PCSK9 Inhibitors in Clinical Practice
by: S. Yu. Volkova, et al.
Published: (2023-03-01)

THE ROLE OF THE PROPROTEIN CONVERTASE SUBTILISIN / KEXIN TYPE 9 (PCSK9) IN THE PATHOPHYSIOLOGY OF ATHEROSCLEROSIS
by: Алексей Михайлович Чаулин, et al.
Published: (2019-12-01)

Effectiveness of Red Watermelon in Preventing Atherosclerosis Through the Role of Lipids, PCSK9, LOX-1, CD36, and ABCA1 in Wistar Rats
by: Mochamad Bahrudin, et al.
Published: (2025-06-01)

Genetic Characterization of the Immortalized Human Nasopharyngeal Carcinoma Cell Line NPC/HK1
by: Anna Makowska, et al.
Published: (2025-02-01)

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease
by: article Editorial
Published: (2023-12-01)

MicroRNA-1912 regulates cholesterol homeostasis by targeting PCSK9
by: Chan Joo Lee, et al.
Published: (2025-09-01)

Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events
by: Sidelnikov E, et al.
Published: (2025-05-01)

PCSK9 in acute coronary syndrome: analysis of associations with clinical and laboratory characteristics
by: Yu. A. Drenina, et al.
Published: (2020-09-01)

PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines
by: A. A. Nekipelova, et al.
Published: (2023-09-01)

PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center
by: A. V. Blokhina, et al.
Published: (2022-01-01)

PCSK9 inhibitors reduces arterial stiffness in patients with acute coronary syndrome
by: Wang Liang, et al.
Published: (2025-01-01)

Pathologic Significance of EBV Encoded RNA in NPC
by: Li, Zhi, et al.
Published: (2012)

Effect of atorvastatin and rosuvastatin on the PCSK9 blood concentration in statin-naive patients with atherosclerosis
by: A. Yu. Filatova, et al.
Published: (2019-06-01)

In vivo adeno-associated virus-mediated LDLR/PCSK9 intervention for familial hypercholesterolemia
by: Zeyu Han, et al.
Published: (2025-11-01)

Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8+ T cells
by: Zhe Xu, et al.
Published: (2025-07-01)

Comparative effectiveness of different methods of prescribing rosuvastatin and ezetimibe in combination with PCSK9 inhibitors
by: A. A. Kuznetsov, et al.
Published: (2024-06-01)

Gene Expression and Methylation Levels of PCSK9 Gene in Iraqi Patients with Coronary Artery Disease
by: Marwa M. Al-Attar, et al.
Published: (2023-12-01)

Munchausen Syndrome by Proxy in Singapore
by: Derrick Yeo, et al.
Published: (2025-06-01)

Single proxy synthetic control
by: Park Chan, et al.
Published: (2025-07-01)

PCSK9 inhibitors for in-hospital treatment of patients with acute coronary syndrome and severe lipid metabolism disorders
by: O. L. Barbarash, et al.
Published: (2020-09-01)

Intensification of lipid-lowering therapy in very high-risk patients: potential of combination with PCSK9 inhibitors
by: D. Yu. Sedykh, et al.
Published: (2022-07-01)

New opportunities for lowering low-density lipoprotein cholesterol: comparative characteristics of PCSK9-targeted therapy
by: S. K. Zyryanov, et al.
Published: (2022-12-01)

Clinical Efficacy of Atorvastatin and PCSK9 Inhibitors in Patients With Borderline Coronary Lesions: An Intravascular Ultrasound Assessment
by: Zeyu Xu BM, et al.
Published: (2025-07-01)

Approaches to Proxy Modeling of Gas Reservoirs
by: Alexander Perepelkin, et al.
Published: (2025-07-01)

Fault Diagnosis Method for Open-circuit Faults in NPC Three-level Inverter based on WKCNN
by: Guozheng Zhang, et al.
Published: (2025-06-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

Human PCSK9D374Y exacerbates methionine choline deficiency diet-induced nonalcoholic steatohepatitis in mice
by: Abidan·ABUDURUSULI, CHEN Xiaocui, CUI Yuanfeng, Tuoluonayi·MIJITI, DENG Lihui, CHEN Bangdang
Published: (2025-05-01)

The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial
by: Yu. A. Karpov
Published: (2019-01-01)

ADAPTIVE FUZZY CACHING ALGORITHM FOR PROXY SERVERS
by: Alexander Igorevich Zhukov
Published: (2012-12-01)

An Algorithm of (n, t)-Threshold Proxy Signature with an Arbitrator
by: E. A. Tolyupa
Published: (2013-08-01)

Munchausen syndrome by proxy: Early recognition and management
by: P. Sreelatha, et al.
Published: (2025-01-01)

Analysis of achievements of NPC Papua disabled athletes in athletics PEPARNAS Event at 2024
by: Kurdi Kurdi, et al.
Published: (2025-07-01)

Choice between three-level NPC and FC topology under SVM control
by: Elbadaoui Sara, et al.
Published: (2025-01-01)

Insights into Binding Mechanisms of Potential Inhibitors Targeting PCSK9 Protein via Molecular Dynamics Simulation and Free Energy Calculation
by: Xingyu Wu, et al.
Published: (2025-07-01)

Sex differences in the treatment with PCSK9 monoclonal antibodies- real world experience from a dedicated preventive cardiology clinic
by: Lital Hodeda, et al.
Published: (2025-09-01)

Real-World Assessment of the Association Between PCSK9i Adherence and LDL Reduction and Variability in a Chinese Clinical Practice
by: Ye X, et al.
Published: (2025-06-01)

Spontaneous Improvement of Hypogonadotropic Hypogonadism in a Patient with <i>PCSK1</i> and <i>HS6ST1</i> Mutations: A Case Report
by: Alanna Asgeirsson, et al.
Published: (2025-07-01)

Causal relationship between allergy and seborrheic dermatitis
by: A. A. Barilo, et al.
Published: (2022-07-01)